Bicycle Therapeutics PLC (BCYC)
22.18
-0.18
(-0.80%)
USD |
NASDAQ |
May 16, 16:00
22.16
-0.02
(-0.11%)
After-Hours: 20:00
Bicycle Therapeutics Shareholders Equity (Quarterly): 356.05M for March 31, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 356.05M |
| December 31, 2023 | 370.93M |
| September 30, 2023 | 416.02M |
| June 30, 2023 | 220.10M |
| March 31, 2023 | 243.16M |
| December 31, 2022 | 270.78M |
| September 30, 2022 | 289.47M |
| June 30, 2022 | 311.39M |
| March 31, 2022 | 330.26M |
| December 31, 2021 | 346.25M |
| September 30, 2021 | 170.82M |
| Date | Value |
|---|---|
| June 30, 2021 | 142.05M |
| March 31, 2021 | 142.09M |
| December 31, 2020 | 95.46M |
| September 30, 2020 | 109.55M |
| June 30, 2020 | 71.03M |
| March 31, 2020 | 81.81M |
| December 31, 2019 | 93.20M |
| September 30, 2019 | 95.32M |
| June 30, 2019 | 104.56M |
| March 31, 2019 | 56.92M |
| December 31, 2018 | -69.83M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
71.03M
Minimum
Jun 2020
416.02M
Maximum
Sep 2023
213.02M
Average
195.46M
Median
Shareholders Equity (Quarterly) Benchmarks
| Biodexa Pharmaceuticals Plc | 5.959M |
| NuCana PLC | 18.96M |
| TC BioPharm (Holdings) PLC | 3.421M |
| Adaptimmune Therapeutics PLC | 39.51M |
| Verona Pharma PLC | 224.99M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 547.14M |
| Total Liabilities (Quarterly) | 191.10M |
| Debt to Equity Ratio | 0.0865 |
| Current Ratio | 10.42 |
| Net Debt Paydown Yield | -0.01% |